Novo Nordisk's pricing strategies while in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of rate gouging, pointing out the stark distinction between U.S. charges and people in Europe and copyright. Scientific tests of Rybelsus and cop